Literature DB >> 16741744

An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome.

Vittorio Fineschi1, Margherita Neri, Sabina Di Donato, Cristoforo Pomara, Irene Riezzo, Emanuela Turillazzi.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a complication occurring in the luteal phase of a menstrual cycle in which ovulation induction or ovarian hyperstimulation for assisted reproduction techniques has been performed. Our report concerns the death of a 31-year-old woman with primary infertility on recombinant follicle stimulating hormone therapy (Gonal-F) who developed a fatal adult respiratory distress syndrome. Immunohistochemical investigation of lung and uterine samples was performed utilizing monoclonal antibodies for antisurfactant apoprotein (PE-10) and polyclonal antibodies anti-IL-6, IL-8, IL-10, TNFalpha for lungs, and polyclonal antibodies anti-beta-HCG (human chorionic gonadotropin) for uterus. The knowledge of macroscopic and histologic findings should be of special interest for all those who perform autopsies in these victims. The exact pathogenesis of OHSS remains a mystery; so for the diagnosis of suspected OHSS, the forensic pathologist must use all the modern laboratory armament to validate the diagnosis in the extremely rare fatal cases due to this syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741744     DOI: 10.1007/s00414-006-0104-z

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  25 in total

1.  The new Italian law on assisted reproduction technology (Law 40/2004).

Authors:  V Fineschi; M Neri; E Turillazzi
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

Review 2.  Ovarian hyperstimulation syndrome: facts and fallacies.

Authors:  C C Beerendonk; P A van Dop; D D Braat; J M Merkus
Journal:  Obstet Gynecol Surv       Date:  1998-07       Impact factor: 2.347

3.  Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study.

Authors:  Y Abramov; U Elchalal; J G Schenker
Journal:  Fertil Steril       Date:  1999-04       Impact factor: 7.329

4.  Thromboembolic phenomena after ovarian stimulation with human gonadotrophins.

Authors:  M Mozes; H Bogokowsky; E Antebi; B Lunenfeld; E Rabau; D M Serr; A David; M Salomy
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

Review 5.  Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

Authors:  D Navot; P A Bergh; N Laufer
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

6.  An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion.

Authors:  S Semba; T Moriya; E M Youssef; H Sasano
Journal:  Pathol Int       Date:  2000-07       Impact factor: 2.534

7.  Forensic application of VEGF expression to skin wound age determination.

Authors:  Takahito Hayashi; Yuko Ishida; Akihiko Kimura; Tatsunori Takayasu; Wolfgang Eisenmenger; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2004-08-03       Impact factor: 2.686

Review 8.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

9.  Markedly elevated cytokines in pleural effusion during the ovarian hyperstimulation syndrome: transudate or ascites?

Authors:  J R Loret de Mola; F Arredondo-Soberon; C P Randle; R T Tureck; M A Friedlander
Journal:  Fertil Steril       Date:  1997-04       Impact factor: 7.329

Review 10.  Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2003 Jan-Feb       Impact factor: 15.610

View more
  7 in total

1.  Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.

Authors:  S P Pakhomov; V S Orlova; I N Verzilina; N V Sukhih; A V Nagorniy; A V Matrosova
Journal:  Arch Razi Inst       Date:  2021-11-30

2.  Sudden death of an egg donor during oocyte retrieval due to ovarian hyperstimulation syndrome.

Authors:  Swati Tyagi; Asit Ranjan Mridha; Chittaranjan Behera
Journal:  Autops Case Rep       Date:  2022-05-27

3.  Nandrolone Decanoate: Use, Abuse and Side Effects.

Authors:  Federico Giuseppe Patanè; Aldo Liberto; Andreana Nicoletta Maria Maglitto; Pasquale Malandrino; Massimiliano Esposito; Francesco Amico; Giuseppe Cocimano; Giuseppe Li Rosi; Dario Condorelli; Nunzio Di Nunno; Angelo Montana
Journal:  Medicina (Kaunas)       Date:  2020-11-11       Impact factor: 2.430

Review 4.  Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.

Authors:  Giuseppe Davide Albano; Francesco Amico; Giuseppe Cocimano; Aldo Liberto; Francesca Maglietta; Massimiliano Esposito; Giuseppe Li Rosi; Nunzio Di Nunno; Monica Salerno; Angelo Montana
Journal:  Healthcare (Basel)       Date:  2021-01-19

5.  Effects of a Plastic-Free Lifestyle on Urinary Bisphenol A Levels in School-Aged Children of Southern Italy: A Pilot Study.

Authors:  Francesco Sessa; Rita Polito; Vincenzo Monda; Alessia Scarinci; Monica Salerno; Marco Carotenuto; Giuseppe Cibelli; Anna Valenzano; Angelo Campanozzi; Maria Pina Mollica; Marcellino Monda; Giovanni Messina
Journal:  Front Public Health       Date:  2021-02-01

6.  Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.

Authors:  Xuan Jiang; Cheng-Yan Deng; Zheng-Yi Sun; Wei-Lin Chen; Han-Bi Wang; Yuan-Zheng Zhou; Li Jin
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

Review 7.  Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.

Authors:  Marco Torrisi; Giuliana Pennisi; Ilenia Russo; Francesco Amico; Massimiliano Esposito; Aldo Liberto; Giuseppe Cocimano; Monica Salerno; Giuseppe Li Rosi; Nunzio Di Nunno; Angelo Montana
Journal:  Medicina (Kaunas)       Date:  2020-11-04       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.